Sage Therapeutics to Present at Goldman Sachs 40th Annual Global Healthcare Conference
June 04 2019 - 6:30AM
Business Wire
Sage Therapeutics (NASDAQ:SAGE), a biopharmaceutical company
developing novel medicines to treat life-altering central nervous
system (CNS) disorders, today announced that the Company will
present at the Goldman Sachs 40th Annual Global Healthcare
Conference on Tuesday, June 11, 2019 at 8:00 a.m. PDT (11:00 a.m.
EDT) in Palos Verdes, Cal.
A live webcast of the presentation can be accessed on the
investor page of Sage's website at investor.sagerx.com. A replay of
the webcast will also be archived for up to 30 days on Sage's
website following the conference.
About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company committed to
developing novel medicines to transform the lives of patients with
life-altering central nervous system (CNS) disorders. Sage’s
portfolio of novel compounds targets critical receptor systems in
the brain and includes the first treatment specifically approved by
the U.S. Food and Drug Administration for postpartum depression as
well as compounds being developed as potential treatments for
diseases such as major depressive disorder, insomnia, bipolar
disorder and essential tremor. For more information, please visit
www.sagerx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190604005130/en/
Investor Contact:Maren Killackey,
617-949-4113maren.killackey@sagerx.comMedia Contact:Jeff
Boyle, 617-949-4256jeff.boyle@sagerx.com
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Apr 2023 to Apr 2024